Prime Medicine PRME
Ownership & positioning
Who holds it, who is betting against it, and where the big money is moving
Short-sale volume as % of daily volume
Large-order net flow, last 20 sessions
Net of large-order buying minus selling, in USD. Over this window: −$4.50M (8 inflow days, 12 outflow days).
Net flow by order size, last 20 sessions
Super/Big orders approximate institutional-size trades; Mid/Small approximate retail-size trades. Net buy minus sell value in each bucket, summed over the window.
The five largest holders on file together own 43.1% of shares outstanding.
Largest holders
By investor type
Reported short interest has fallen from 19.31% to 16.07% of float over the last 6 biweekly reports (14 Aug 2026 to 30 Oct 2026).
Recent institutional activity
| Holder | Type | Period | Share change | New stake |
|---|---|---|---|---|
| GWL Investment Management Ltd. | Mutual Fund | 2026/Q3 | +136,523 | 0.1% |
| ARK Investment Management LLC | Mutual Fund | 2026/Q3 | +1,694,763 | 5.6% |
| BlackRock | Mutual Fund | 2026/Q3 | +1,113,772 | 6.0% |
| Amova Asset Management | Mutual Fund | 2026/Q3 | +498,612 | 1.6% |
| Sumitomo Mitsui Trust Asset Management | Mutual Fund | 2026/Q3 | +498,612 | 1.6% |
| Alessandra Capital Management, LLC | Family Office/Trust | 2026/Q3 | +134,170 | 0.4% |
| Russell Investment Management, LLC | Mutual Fund | 2026/Q3 | +124,506 | 0.1% |
| Barclays PLC | Public Company | 2026/Q3 | +121,163 | 0.1% |
| Pekin Hardy Strauss, Inc. | Mutual Fund | 2026/Q3 | +114,500 | 0.1% |
| Nuveen Asset Management LLC | Insurance Company | 2026/Q3 | +245,007 | 0.1% |
| ARK Investment Management LLC | Mutual Fund | 2026/Q3 | +2,101,919 | 4.7% |
| The Goldman Sachs Group, Inc. | Public Company | 2026/Q3 | +2,029,275 | 1.3% |
| Citadel Advisors LLC | Hedge Fund | 2026/Q3 | +1,718,185 | 1.2% |
| Leap Investments LP | Mutual Fund | 2026/Q3 | +1,239,598 | 0.7% |
| State Street Global Advisors | Mutual Fund | 2026/Q3 | +1,231,335 | 4.3% |
Institutional buy/sell activity by reporting period, largest moves first.
Insider transactions
| Date | Insider | Title | Transaction | Shares | Price | Held after |
|---|---|---|---|---|---|---|
| 4 Jun 2026 | Robert Taylor Nelsen | Independent Director | Other Derivative Acquisition | +75,000 | $3.06 | 75,000 |
| 4 Jun 2026 | Michael Kelly | Independent Director | Other Derivative Acquisition | +75,000 | $3.06 | 75,000 |
| 4 Jun 2026 | Kaye Foster-Cheek | Independent Director | Other Derivative Acquisition | +75,000 | $3.06 | 75,000 |
| 4 Jun 2026 | David Schenkein | Independent Director | Other Derivative Acquisition | +75,000 | $3.06 | 75,000 |
| 4 Jun 2026 | Jeffrey Marrazzo | Executive Chairperson | Other Derivative Acquisition | +75,000 | $3.06 | 75,000 |
| 4 Jun 2026 | Wendy Chung | Independent Director | Other Derivative Acquisition | +75,000 | $3.06 | 75,000 |
| 4 Jun 2026 | Thomas Cahill | Independent Director | Other Derivative Acquisition | +75,000 | $3.06 | 75,000 |
| 25 Feb 2026 | Allan Reine | Chief Executive Officer | Other Derivative Acquisition | +1,300,000 | $4.38 | 1,300,000 |
| 22 Feb 2026 | Ann Lee | Chief Technology Officer | Other Derivative Acquisition | +375,000 | $3.34 | 375,000 |
| 22 Feb 2026 | Carman Alenson | Former Senior VP of Finance & Chief Accounting Officer | Other Derivative Acquisition | +140,000 | $3.34 | 140,000 |
| 31 Jul 2025 | Robert Taylor Nelsen | Independent Director | Derivative Sale to Issuer | -84,062 | – | – |
| 31 Jul 2025 | Robert Taylor Nelsen | Independent Director | Other Derivative Acquisition | +84,062 | $4.04 | 45,000 |
| 31 Jul 2025 | Michael Kelly | Independent Director | Derivative Sale to Issuer | -106,578 | – | – |
| 31 Jul 2025 | Michael Kelly | Independent Director | Other Derivative Acquisition | +106,578 | $4.04 | 45,000 |
| 31 Jul 2025 | Kaye Foster-Cheek | Independent Director | Derivative Sale to Issuer | -106,578 | – | – |
| 31 Jul 2025 | Kaye Foster-Cheek | Independent Director | Other Derivative Acquisition | +106,578 | $4.04 | 45,000 |
| 31 Jul 2025 | David Schenkein | Independent Director | Derivative Sale to Issuer | -84,062 | – | – |
| 31 Jul 2025 | David Schenkein | Independent Director | Other Derivative Acquisition | +84,062 | $4.04 | 45,000 |
| 31 Jul 2025 | Ann Lee | Chief Technology Officer | Derivative Sale to Issuer | -361,990 | – | – |
| 31 Jul 2025 | Ann Lee | Chief Technology Officer | Other Derivative Acquisition | +361,990 | $4.04 | 180,995 |
From Form 4/Form 144 filings. Negative share counts are disposals (sales, gifts, or shares withheld for taxes); positive are acquisitions.
Short interest, by report
| Report date | Shares short | % of float | Days to cover |
|---|---|---|---|
| 30 Oct 2026 | 29,147,049 | 16.1% | 4.8 |
| 15 Oct 2026 | 32,871,532 | 18.1% | 5.5 |
| 30 Sep 2026 | 32,116,376 | 17.7% | 8.5 |
| 15 Sep 2026 | 32,132,218 | 17.7% | 12.3 |
| 31 Aug 2026 | 36,761,940 | 20.3% | 13.1 |
| 14 Aug 2026 | 35,022,290 | 19.3% | 13.8 |
No comments yet — be the first to weigh in on PRME.
Sign in to join the discussion.